Early Detection and Prevention of Mild Cognitive Impairment (R01)

Post Date

March 21st 2012

Application Due Date

May 21st 2012

Funding Opportunity Number

RFA-NR-12-010

CFDA Number(s)

93.361

Funding Instrument Type(s)

Grant

Funding Activity Categories

Education
Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in theNIH Grants Policy Statement, are not allowed.

Funding

• Estimated Total Funding:

  $2500000

• Award Range:

  $None - $350000

Grant Description

The National Institute of Nursing Research (NINR) seeks to stimulate research into technologies that have the greatest future impact for pre-symptomatic detection and preventive treatment and management of age- or treatment-related mild cognitive impairment (MCI), including those occurring in the setting of Life Limiting Illnesses (LLI). Early detection or prevention of MCI prior to the development of clinical symptoms can have a significant impact on treatment options and ultimately quality of life. It is anticipated that findings from this research can improve our ability to identify at risk individuals and prevent or delay further neurodegeneration.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-NR-12-010.html